New York K 148: Memorializing Governor Andrew M. Cuomo to proclaim April 8, 2021, as Library Assistants' Day in the State of New York

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 - This bill is not active in this session.

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
K00148 Summary:

BILL NOK00148 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORRaga

&nbsp

COSPNSR

&nbsp

MLTSPNSRButtenschon, Epstein, Gonzalez-Rojas, Griffin, Hyndman, Jones, Levenberg, Lupardo, McDonald,
 O'Pharrow, Rozic, Santabarbara, Seawright, Shimsky, Simon, Weprin

&nbsp

&nbsp

Go to top K00148 Actions:

BILL NOK00148 

&nbsp

02/28/2025referred to calendar

03/03/2025adopted

Go to topK00148 Committee&nbspVotes:

Go to topK00148 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topK00148 Text:

Assembly Resolution No. 148

BY: M. of A. Raga

 MEMORIALIZING Governor Kathy Hochul to proclaim
 March 2025, as Multiple Sclerosis Awareness Month in
 the State of New York

 WHEREAS, It is the custom of this Legislative Body to recognize
official months that are set aside to increase awareness of serious
illnesses that affect the lives of citizens of New York State; and

 WHEREAS, Attendant to such concern, and in full accord with its
long-standing traditions, this Legislative Body is justly proud to
memorialize Governor Kathy Hochul to proclaim March 2025, as Multiple
Sclerosis Awareness Month in the State of New York; and

 WHEREAS, New Yorkers place the highest priority on health-related
issues, including the various forms of auto-immune and neurological
conditions striking people of all ages, and one of the most prevalent is
Multiple Sclerosis (MS), which the National MS Society estimates affects
nearly one million Americans, with an estimated 200 new cases diagnosed
each week, or one person every hour of the day; and

 WHEREAS, MS affects the Central Nervous System (CNS), and those who
suffer from it have damage done to myelin in the CNS due to overactive
immune cells which cause inflammation; over time, lesions caused by MS
harden into scar tissue, or sclerosis, and may develop at multiple
points in the CNS; this phenomenon is where the disease's name, Multiple
Sclerosis, is derived; and

 WHEREAS, Due to the complexity of the CNS, the disease can cause a
wide range of different symptoms and currently, there are more than 50
recognized symptoms that range from mild to life-altering, making it
impossible to predict which symptoms any one individual may experience;
and

 WHEREAS, While there are a variety of treatments available to slow
the progress of MS, there are no treatments that can stop or reverse the
damage caused by the disease; early damage to the CNS can occur even
before an individual experiences symptoms, therefore, the best chances
to reduce long-term disability is during the early phase of the disease;
currently, most people with MS have a normal or near normal life
expectancy; and

 WHEREAS, MS is more common in women and appears more frequently in
Caucasian women than Hispanic, Asian, or African American women; two to
three times more women are diagnosed with the disease than men; and

 WHEREAS, While MS is not considered an inherited disorder, there may
be genetic predispositions to the disease; if you have a parent or
sibling diagnosed with MS, your chance to also have the condition is
raised to 2.5 percent, and a person with an identical twin who is
diagnosed with MS have a 25 percent chance of also developing it; and

 WHEREAS, MS is the second most costly chronic condition to manage;
the average cost of disease modifying therapies in the United States is

approximately $60,000 per year, and the total cost per person with MS is
estimated to be $4.1 million; and

 WHEREAS, A number of non-profit health organizations, such as the
New York City-Southern New York, Long Island and Upstate New York
Chapters of the National MS Society, are dedicated to the ultimate goal
of eradicating Multiple Sclerosis and to serving those currently living
with the disease; and

 WHEREAS, The National MS Society is steadfast in its efforts to find
cures for the disease through medical research, voluntary contributions
and public support; in New York State, the Society serves over 34,000
people living with MS by maintaining offices in Albany, Binghamton,
Buffalo, Syracuse, Rochester, Westchester County, Long Island and New
York City to carry out its compassionate work on behalf of individuals
with the disease and to assist their family members; and

 WHEREAS, Today, of the nearly